Fen-Phen Lawyer, Cynthia K. Garrett, has been representing Pondimin & Redux victims since 1998. Accepting new Fen-Phen clients nationwide. Fen-Phen lawsuits and settlement claims are still being filed and paid.
Fen Phen deaths can be caused by a number of medical conditions that arise from an underlying aortic or mitral valve injury caused by Pondimin or Redux, the diet drugs that were part of the Fen Phen diet combination. We are accepting new Pondimin and Redux clients. Deadlines apply to when an injury must occur in order to qualify for compensation, and when you must file your claim for that injury. See below to learn what deadlines apply to you.
For death due to primary pulmonary hypertension click here to be taken to the PPH IPAH page.
Fen-Phen is the common name of a weight loss protocol heavily marketed in the 1990's that included fenfluramine (Pondimin) or dexfenfluramine (Redux). Pondimin and Redux were shown to cause damage to the mitral and aortic heart valves; and a serious lung condition called primary pulmonary hypertension.
Pondimin and Redux were withdrawn from the U.S. market in 1997. The AHP Settlement only includes those who used Pondimin or Redux.
The AHP Settlement Trust was established to administer the aortic and mitral valve injury claims of registered Pondimin or Redux users.
Fen Phen valve injury claims can still be filed for those who meet the Baseline Requirements listed below and are included in one of the two groups below.
1) Supplemental Claims for worsened injuries may be filed by those who:
2) Original Claims may possibly be filed by those who:
3) Those who were included in the Seventh Amendment Settlement Fund may no longer file claims.
All deadlines for have passed for these persons. See details of the Seventh Amendment below.
Registered with the AHP Settlement Trust on or before May 3, 2003.
If you are not a doctor, or a lawyer currently familiar with Fen Phen injuries, these definitions can be overwhelming. To assist you, we provide above the criteria we use to determine if we are interested in reviewing a case. During a case review we will compare the injuries suffered to the official AHP Settlement Trust criteria.
If you think you may have a viable claim, review Our Initial Criteria For Fen Phen Case Review below. If you meet all of the Basic Criteria, and at least one of the Additional Criteria, contact us immediately to speak with an attorney about your case.
Seventh Amendment participants may no longer file claims. All deadlines for these persons have expired.
Those Pondimin and Redux users who met the definition of a Category 1 or 2 Claimant - as defined in the Seventh Amendment to the AHP Settlement Agreement - were automatically included as participants in the Seventh Amendment Supplemental Fund unless the claimant filed an opt-out form by November 9, 2004.
The definition of Category 1 includes those who had an unresolved Green Form on file on November 9, 2004, which supported a Level I or II injury.
The definition of Category 2 includes those who:
Fen Phen lawsuits are filed in Federal Court by those who took Pondimin or Redux, have been diagnosed with Primary Pulmonary Hypertension - which is also called Idiopathic Pulmonary Arterial Hypertension - and are now seeking financial compensation for their injuries. If that person is deceased, a court-appointed personal representative may file the lawsuit on behalf of the deceased Fen Phen user's estate.
Fen Phen class action claims are filed with the AHP Settlement Trust - the trust established by court order to administer and pay claims associated with aortic or mitral valve injuries. These claims seek financial compensation for the injured and their derivative beneficiaries. If the injured Fen Phen user is deceased, a court-appointed personal representative may file the claim.
Fen-Phen is frequently misspelled as: fen-fen, phen-phen, or fin-fin. This litigation only includes those who took Pondimin or Redux. It does not cover alleged injuries from other diet drugs including those taken with Pondimin or Redux. Fen-Phen lawsuits and Fen-Phen claims relate only to Pondimin and Redux.
Cynthia K. Garrett, Attorney at Law
7136 S. Yale Ave., Suite 300, Tulsa, OK 74136
866-584-0070. . . . . . . . . CKG@CKGLAWFIRM.COM
Copyright © 2021, Cynthia K. Garrett, Attorney at Law. All Rights Reserved.
Communication through this website does not constitute legal advice, nor create an attorney/client relationship.